DFTX
Definium Therapeutics, Inc.
37.40$
-0.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | -33.3% | – | – | – | – | – | – | – | – | -200.0% | – | |
| – | -13.0% | +0.4% | +47.2% | -30.6% | -8.6% | -0.6% | +53.3% | +10.7% | +96.3% | -37.5% | +35.2% | – | |
| – | – | – | – | – | -105.5% | – | – | +0.1% | -155.3% | – | +15.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -75.7% | – | +143.6% | +11.9% | -854.1% | – | |
| – | – | – | – | – | +668.8% | -100.0% | – | -97.7% | -100.0% | – | – | – | |
| – | -85.1% | +6,427.1% | -93.6% | +542.9% | -94.5% | -73.7% | +1,861.1% | -96.2% | +32,826.2% | -97.8% | +14,258.0% | – | |
| – | -2,338.2% | – | -106.0% | – | -141.3% | – | – | – | – | -98.0% | +8,290.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.